INVEST IN THE BABE RUTH OF GLOBAL STOCKS

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.

Since December 1990, Teva has skyrocketed from 66 cents to $44.95. Early investors in Teva have made 68 times their money. That’s better than master investor Warren Buffett (a 13x return over the same period) -or even high profile U.S.-based success stories like Starbucks (a 36x return since 1992).

Here’s why we think Teva (TEVA) — this week’s Global Bull Market Alert pick — will continue to generate big profits for investors well into 2006.

As a global generic drug maker, Teva is poised to take advantage of drugs coming off patents. Generic drugs are set to enjoy a banner year in 2006. Six blockbuster drugs with sales of more than $1 billion each are set to go off-patent in the U.S., ranging from Merck’s Zocor and Sanofi-Aventis’ Ambien to Bristol-Myers Squibb’s Pravachol and Pfizer’s Zoloft.

Just about $23 billion in products will lose exclusivity, with more than $18 billion of that coming from the U.S. With an estimated 10% share of the generic drug market, Teva will reap big profits in the next few years from this development.

Teva is also well set to take advantage of a bird-flu crisis, should one erupt. Swiss drug giant Roche, in a move to silence criticism that it’s guarding the formula for its bird-flu drug too closely, has reached agreements with Teva (as well as a handful of other drug producers) for the production of Tamiflu. That means any bad news on that front will send Teva’s stock soaring.

Finally, Teva’s stock is exhibiting all the technical characteristics we like — it is a steady performer that remains unruffled by political uncertainty in its home market of Israel.

Exclusive  Locking in 92.73% Gains; And Betting on the Top-Performing Global Stock Market of 2012

So buy Teva at market today and place your initial stop at $39.50. If you want to play Teva’s continued upswing into 2006, buy the June $50 call options. (TVQFJ.X).

Portfolio Update — Lock in 88% Gains with Sify in One Week!

The options in last week’s Global Bull Market Alert pick, Indian internet company Sify (SIFY), skyrocketed 88%, with the stock itself up 17%. It doesn’t get much better than this, so take profits on half your options (SUYCB.X) and move your stop price to $7.90.

To make room for Teva, take profits on Norsk Hydro (NHY), where we’ve made a quick profit of close to 5%, for an annualized return of 59%.

With Japanese financial giant Mitsubishi UFJ (MTU) up sharply this week on the stronger yen, move your stop up to $12.40.

Our Global Bull Market Alert stock picks have gotten off to a strong start. All of our selections have made money, with some registering gains as high as 26%.

In addition to this week’s 88% gain in Sify, those of you who have played our option recommendations have recorded triple-digit gains in both America Movil (125%) and Elan (128%).

Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE


img
previous article

Elan (ELN) continues its relentless path upward, with the stock up another 10.8% this week. It¢â‚¬â„¢s up 32% since we recommended it less than three weeks ago.

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Mike Turner

Mike Turner’s financial, mathematical, computer science and engineering background serves as the foundation for his disciplined, rules-based approach to trading. Mike’s three services include:

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE